SEC Comment Letter 0000000000-22-013561 to BIO-RAD LABORATORIES, INC. (BIO, BIO-B) (CIK 0000012208) (BIO)
BIO-RAD LABORATORIES, INC. (BIO, BIO-B) (CIK 0000012208)
Date: Dec. 16, 2022 · CIK: 0000012208 · Accession: 0000000000-22-013561
AI Filing Summary & Sentiment
File numbers found in text: 001-07928
Letter
United States securities and exchange commission logo December 16, 2022 Ajit Ramalingam Senior Vice President, Chief Accounting Officer Bio-Rad Laboratories, Inc. 1000 Alfred Nobel Drive Hercules, CA 94547 Re:Bio-Rad Laboratories, Inc. Form 10-K for the year ended December 31, 2021 File No. 001-07928 Dear Ajit Ramalingam: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services
Show Raw Text
United States securities and exchange commission logo
December 16, 2022
Ajit Ramalingam
Senior Vice President, Chief Accounting Officer
Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules, CA 94547
Re:Bio-Rad Laboratories, Inc.
Form 10-K for the year ended December 31, 2021
File No. 001-07928
Dear Ajit Ramalingam:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services